Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 161 - 170 of 200 for wx. (0.06 seconds)

Pharmaron, China’s third-largest CRO, announced a...
Fosun Pharma expects tor raise $600 million in its...
Innovent Biologics, a Suzhou company formed last year, is...
WuXi PharmaTech, a CRO known mostly for its pre-clinical...
WuXi PharmaTech is forming a JV with PRA, a US-based...
Sinopharm Holdings, one of China’s big-three drug...
Syros Pharmaceuticals of Boston raised $30 million to...
Shanghai Fosun Pharma, Chindex and a private equity...
RuiYi Inc., a San Diego-Shanghai biotech, signed an...
Zhejiang Medicine Co. formed a collaboration with Ambrx...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here